Literature DB >> 25299136

Phenylalanine binding is linked to dimerization of the regulatory domain of phenylalanine hydroxylase.

Shengnan Zhang1, Kenneth M Roberts, Paul F Fitzpatrick.   

Abstract

Analytical ultracentrifugation has been used to analyze the oligomeric structure of the isolated regulatory domain of phenylalanine hydroxylase. The protein exhibits a monomer-dimer equilibrium with a dissociation constant of ~46 μM; this value is unaffected by the removal of the 24 N-terminal residues or by phosphorylation of Ser16. In contrast, phenylalanine binding (Kd = 8 μM) stabilizes the dimer. These results suggest that dimerization of the regulatory domain of phenylalanine hydroxylase is linked to allosteric activation of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25299136      PMCID: PMC4251497          DOI: 10.1021/bi501109s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


Phenylalanine hydroxylase (PheH) is an allosteric enzyme that catalyzes the hydroxylation to tyrosine of excess phenylalanine in the diet.[1] Incubation with phenylalanine increases the activity up to 100-fold;[2] this is accompanied by conformational changes in the interface between the regulatory and catalytic domains.[3] Phosphorylation of Ser16 decreases the concentration of phenylalanine required to activate PheH.[4] The present understanding of the mechanism of phenylalanine activation is based on a crystal structure of PheH[5] in which N-terminal residues 19–29 of the regulatory domain lie across the active site of the catalytic domain. Binding of phenylalanine is proposed to result in a conformational change that displaces the N-terminus of the regulatory domain and opens the active site.[5] PheH belongs to the family of aromatic amino acid hydroxylases, along with tyrosine hydroxylase (TyrH) and tryptophan hydroxylase.[6] The structures of the catalytic domains of all three are very similar,[5,7,8] consistent with a common catalytic mechanism.[9] The regulatory domains of PheH and TyrH also have similar structures,[5,10] although they display very low levels of sequence identity. However, the solution structure of the isolated regulatory domain of TyrH shows that the protein forms a stable ACT domain dimer,[10] whereas the crystal structure of the combined regulatory and catalytic domains of PheH shows no interactions between individual regulatory domains.[5] Preliminary characterization of the isolated regulatory domain of PheH, residues 1–117 (RDPheH), revealed that the free domain has an apparent molecular weight between that of a monomer and that of a dimer.[11] In part on the basis of this observation, Jaffe et al.[12] proposed that the conformational change that occurs upon binding of phenylalanine to PheH involves dimerization of the regulatory domains. Here we describe the use of analytical ultracentrifugation (AUC) to analyze the oligomerization state of RDPheH to determine whether dimerization of this domain is linked to phenylalanine binding and phosphorylation. Initial sedimentation velocity (SV) experiments were performed at two concentrations of RDPheH; the resulting van Holde–Weischet distributions[13] are shown in Figure 1A. The sedimentation distributions show a concentration dependence, in that the sample with a loading concentration of 280 μM has an s value larger than that of the sample with a loading concentration of 7 μM. The weight-average sedimentation coefficients (sw) for both samples are between those calculated for a monomer and a dimer based on the published structures of the regulatory domains of PheH and TyrH, consistent with a monomer–dimer equilibrium for RDPheH.
Figure 1

Sedimentation velocity analyses of RDPheH. (A) van Holde–Weischet distribution plot for 7 μM RDPheH (red), 280 μM RDPheH (green), and 7 μM RDPheH with 1 mM phenylalanine (blue). (B) Weight-average sedimentation coefficients (sw) as a function of the concentration of RDPheH (red squares), phosphorylated RDPheH (blue triangles), and RDPheH25–117 (black circles). The lines are from fits of eq 1. (C) Effect of the concentration of phenylalanine on the sw of RDPheH25–117 (7.6 μM, red, or 7.2 μM, blue). The line was generated using the mechanism of Scheme 1 and the values listed in Table 1.

To analyze this equilibrium more quantitatively, a series of SV experiments were conducted at 2.5–206 μM RDPheH. The resulting sw values[14] are plotted in Figure 1B as a function of protein concentration. These data were fit well by eq 1, which describes the effect of protein concentration on the average sw value for a monomer–dimer equilibriumwhere s1 and s2 are the sedimentation coefficients of the monomer and dimer, respectively, K is the equilibrium constant for dimer formation, and c is the total molar concentration of the protein in terms of monomer. The resulting values are listed in Table 1.
Table 1

Sedimentation Coefficients and Dissociation Constants for RDPheH

 s1 (S)s2 (S)K1 (μM)a
RDPheHb1.38 ± 0.082.31 ± 0.1346 ± 35
RDPheH25–117b1.24 ± 0.052.17 ± 0.0746 ± 19
phosphorylated RDPheHb1.36 ± 0.052.32 ± 0.1037 ± 18
RDPheH25–117c1.22 (1.14–1.29)2.11 (2.11–2.12)34 (22–56)

Dissociation constant for dimerization.

Based on eq 1.

From global analyses using KinTek Explorer.

Sedimentation velocity analyses of RDPheH. (A) van Holde–Weischet distribution plot for 7 μM RDPheH (red), 280 μM RDPheH (green), and 7 μM RDPheH with 1 mM phenylalanine (blue). (B) Weight-average sedimentation coefficients (sw) as a function of the concentration of RDPheH (red squares), phosphorylated RDPheH (blue triangles), and RDPheH25–117 (black circles). The lines are from fits of eq 1. (C) Effect of the concentration of phenylalanine on the sw of RDPheH25–117 (7.6 μM, red, or 7.2 μM, blue). The line was generated using the mechanism of Scheme 1 and the values listed in Table 1.
Scheme 1

RDPheH Dimerization Model

The structure of PheH containing both the catalytic and regulatory domains[5] shows the ∼20 N-terminal residues to be unstructured. To determine the effect of this N-terminal region on dimerization, a series of mutants of the RDPheH lacking ∼20 N-terminal residues were constructed. The protein lacking the 24 N-terminal residues (RDPheH25–117) was the best-behaved in solution. The results of an SV analysis of the solution behavior of RDPheH25–117 are shown Figure 1B. The dissociation constant of RDPheH25–117 obtained from this analysis is very close to that of RDPheH (Table 1), establishing that the 24 N-terminal residues have no significant effect on dimerization. The 1H–15N heteronuclear single-quantum coherence nuclear magnetic resonance spectrum of RDPheH25–117 overlaps with that of RDPheH (data not shown), establishing that the deletion did not alter the structure. Next, AUC was used to determine whether phosphorylation alters the monomer–dimer equilibrium. As shown in Figure 1B (green) and Table 1, the effect of protein concentration on the sedimentation behavior of RDPheH is unaffected by phosphorylation of the protein. In contrast to the lack of an effect of phosphorylation, phenylalanine has a substantial effect on the sedimentation behavior. Addition of 1 mM phenylalanine to 7 μM RDPheH results in an increase in the s value of the protein to a value consistent with a dimer (Figure 1A). SV analyses were conducted with a fixed concentration of RDPheH25–117 (∼7 μM total monomer) and a range of phenylalanine concentrations (4.8–1500 μM). The resulting sw values are shown in Figure 1C as a function of phenylalanine concentration. There is a clear increase in the average sw value as the concentration of phenylalanine increases. Dissociation constant for dimerization. Based on eq 1. From global analyses using KinTek Explorer. The data in panels B and C of Figure 1 for RDPheH25–117 were analyzed globally[15] to evaluate individual dimerization models and calculate values for the equilibrium constants for phenylalanine binding and dimerization. The model shown in Scheme 1, which involves binding of two molecules of phenylalanine per dimer with equal affinity, gave the best fit (χ2 = 0.339) with a Kd value for phenylalanine of 8.3 μM (6.4–13 μM) and the values listed in Table 1. A model in which the affinities for the first and second molecules of phenylalanine differ gave values for Kphe-1 and Kphe-2 of 13 and 4.6 μM, respectively, but did not yield an improvement in the χ2 value (0.335). A model in which only one phenylalanine binds to the dimer resulted a much higher χ2 value (0.561). The data presented here support a model in which the isolated RDPheH is present in a monomer–dimer equilibrium, with phenylalanine binding stabilizing the dimer. The data support the model of Jaffe et al.[12] in which the structural change associated with phenylalanine activation involves dimerization of regulatory domains within the PheH tetramer. While these results do not address the structure of the dimer, the finding that the isolated regulatory domain of TyrH is an ACT domain dimer[10,16] and the similar structures of the regulatory domains of the two proteins suggest that the RDPheH dimer is also an ACT domain dimer. The lack of an effect of phosphorylation at Ser16 on dimerization suggests that phosphorylation of this residue disrupts interactions of the ∼20 N-terminal residues with the catalytic domain of the enzyme. Weakening such an interaction would make formation of the proposed regulatory domain dimer more favorable. The lack of an effect of deleting the 24 N-terminal residues on dimerization is also consistent with these residues interacting with the catalytic domain.
  15 in total

1.  Crystal structure of tyrosine hydroxylase at 2.3 A and its implications for inherited neurodegenerative diseases.

Authors:  K E Goodwill; C Sabatier; C Marks; R Raag; P F Fitzpatrick; R C Stevens
Journal:  Nat Struct Biol       Date:  1997-07

Review 2.  Mechanism of aromatic amino acid hydroxylation.

Authors:  Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2003-12-09       Impact factor: 3.162

3.  Sedimentation velocity analytical ultracentrifugation and SEDFIT/c(s): limits of quantitation for a monoclonal antibody system.

Authors:  John P Gabrielson; Theodore W Randolph; Brent S Kendrick; Michael R Stoner
Journal:  Anal Biochem       Date:  2006-11-28       Impact factor: 3.365

Review 4.  The ACT domain: a small molecule binding domain and its role as a common regulatory element.

Authors:  Gregory A Grant
Journal:  J Biol Chem       Date:  2006-09-20       Impact factor: 5.157

5.  Global kinetic explorer: a new computer program for dynamic simulation and fitting of kinetic data.

Authors:  Kenneth A Johnson; Zachary B Simpson; Thomas Blom
Journal:  Anal Biochem       Date:  2008-12-25       Impact factor: 3.365

6.  A new model for allosteric regulation of phenylalanine hydroxylase: implications for disease and therapeutics.

Authors:  Eileen K Jaffe; Linda Stith; Sarah H Lawrence; Mark Andrake; Roland L Dunbrack
Journal:  Arch Biochem Biophys       Date:  2013-01-11       Impact factor: 4.013

7.  Structural basis of autoregulation of phenylalanine hydroxylase.

Authors:  B Kobe; I G Jennings; C M House; B J Michell; K E Goodwill; B D Santarsiero; R C Stevens; R G Cotton; B E Kemp
Journal:  Nat Struct Biol       Date:  1999-05

8.  Regulation of phenylalanine hydroxylase: conformational changes upon phenylalanine binding detected by hydrogen/deuterium exchange and mass spectrometry.

Authors:  Jun Li; Lawrence J Dangott; Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2010-04-20       Impact factor: 3.162

9.  Direct evidence for a phenylalanine site in the regulatory domain of phenylalanine hydroxylase.

Authors:  Jun Li; Udayar Ilangovan; S Colette Daubner; Andrew P Hinck; Paul F Fitzpatrick
Journal:  Arch Biochem Biophys       Date:  2010-10-14       Impact factor: 4.013

10.  Phosphorylation of recombinant human phenylalanine hydroxylase: effect on catalytic activity, substrate activation and protection against non-specific cleavage of the fusion protein by restriction protease.

Authors:  A P Døskeland; A Martinez; P M Knappskog; T Flatmark
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

View more
  20 in total

Review 1.  X-ray Scattering Studies of Protein Structural Dynamics.

Authors:  Steve P Meisburger; William C Thomas; Maxwell B Watkins; Nozomi Ando
Journal:  Chem Rev       Date:  2017-05-30       Impact factor: 60.622

2.  The phenylketonuria-associated substitution R68S converts phenylalanine hydroxylase to a constitutively active enzyme but reduces its stability.

Authors:  Crystal A Khan; Steve P Meisburger; Nozomi Ando; Paul F Fitzpatrick
Journal:  J Biol Chem       Date:  2019-01-23       Impact factor: 5.157

3.  Simulations of the regulatory ACT domain of human phenylalanine hydroxylase (PAH) unveil its mechanism of phenylalanine binding.

Authors:  Yunhui Ge; Elias Borne; Shannon Stewart; Michael R Hansen; Emilia C Arturo; Eileen K Jaffe; Vincent A Voelz
Journal:  J Biol Chem       Date:  2018-10-04       Impact factor: 5.157

4.  Domain Movements upon Activation of Phenylalanine Hydroxylase Characterized by Crystallography and Chromatography-Coupled Small-Angle X-ray Scattering.

Authors:  Steve P Meisburger; Alexander B Taylor; Crystal A Khan; Shengnan Zhang; Paul F Fitzpatrick; Nozomi Ando
Journal:  J Am Chem Soc       Date:  2016-05-12       Impact factor: 15.419

5.  First structure of full-length mammalian phenylalanine hydroxylase reveals the architecture of an autoinhibited tetramer.

Authors:  Emilia C Arturo; Kushol Gupta; Annie Héroux; Linda Stith; Penelope J Cross; Emily J Parker; Patrick J Loll; Eileen K Jaffe
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

6.  Phosphorylation of Phenylalanine Hydroxylase Increases the Rate Constant for Formation of the Activated Conformation of the Enzyme.

Authors:  Crystal A Khan; Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2018-10-24       Impact factor: 3.162

7.  The regulatory domain of human tryptophan hydroxylase 1 forms a stable dimer.

Authors:  Shengnan Zhang; Cynthia S Hinck; Paul F Fitzpatrick
Journal:  Biochem Biophys Res Commun       Date:  2016-05-30       Impact factor: 3.575

Review 8.  Structural insights into the regulation of aromatic amino acid hydroxylation.

Authors:  Paul F Fitzpatrick
Journal:  Curr Opin Struct Biol       Date:  2015-07-31       Impact factor: 6.809

9.  Identification of the Allosteric Site for Phenylalanine in Rat Phenylalanine Hydroxylase.

Authors:  Shengnan Zhang; Paul F Fitzpatrick
Journal:  J Biol Chem       Date:  2016-01-28       Impact factor: 5.157

10.  The Amino Acid Specificity for Activation of Phenylalanine Hydroxylase Matches the Specificity for Stabilization of Regulatory Domain Dimers.

Authors:  Shengnan Zhang; Andrew P Hinck; Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2015-08-13       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.